loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 50715 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NOVARTIS (3)

filter

01 CAPSULE;ORAL (3)

filter

01 DISCN (1)

02 RX (2)

filter

01 NEORAL (3)

filter

01 Yes (3)

URL Supplier Web Content
CAPSULE; ORAL
50MG **Federal Reg...
1995-07-14
50715
NEORAL
DISCN
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
25MG
1995-07-14
50715
NEORAL
RX
Yes
AB1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
100MG
1995-07-14
50715
NEORAL
RX
Yes
AB1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 50715

Looking for FDA Orange Book APPLICATION 50715 3

19

Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is CYCLOSPORINE, with a corresponding application number 50715.

Regulatory Information DISCN

With a dosage strength 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 1995-07-14

18

Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is CYCLOSPORINE, with a corresponding application number 50715.

Regulatory Information RX

With a dosage strength 25MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 1995-07-14

Therapeutic Equivalence (TE) Code AB1

17

Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is CYCLOSPORINE, with a corresponding application number 50715.

Regulatory Information RX

With a dosage strength 100MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 1995-07-14

Therapeutic Equivalence (TE) Code AB1

Post Enquiry
POST ENQUIRY